(Q39077443)

8 September 2017

title

Content validity of the NCCN-FACT ovarian symptom index-18 (NFOSI-18). (English)

1 reference

8 September 2017

5

David Cella

1 reference

8 September 2017

Sally E Jensen

1

1 reference

8 September 2017

Karen Kaiser

series ordinal

2

1 reference

8 September 2017

Leilani Lacson

series ordinal

3

1 reference

8 September 2017

Julian Schink

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

8 December 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

136

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

317-322

1 reference

8 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

A new index of priority symptoms in advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

How Many Interviews Are Enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Identifying symptoms of ovarian cancer: a qualitative and quantitative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Development and psychometric properties of the PROMIS(®) pediatric fatigue item banks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Reliability and validity of the functional assessment of cancer therapy-ovarian.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.002

10.1016/J.YGYNO.2014.12.002

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference